Focal ablation of prostate cancer: Four roles for magnetic resonance imaging guidance

Canadian Journal of Urology

Volumn 20, Issue 2, 2013, Pages 6672-6681

  Sommer, Graham ^a   Bouley, Donna ^a   Gill, Harcharan ^a   Daniel, Bruce ^a   Pauly, Kim Butts ^a   Diederich, Chris ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Ablation; Focal interstitial; Focal transurethral therapy; MRI; Prostate cancer; Therapeutic ultrasound

Indexed keywords

ABLATION THERAPY; ANIMAL; CRYOTHERAPY; DISEASE MODEL; DOG; HUMAN; LOW LEVEL LASER THERAPY; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROSTATE TUMOR; REVIEW; ULTRASOUND THERAPY;

ABLATION TECHNIQUES; ANIMALS; CRYOTHERAPY; DISEASE MODELS, ANIMAL; DOGS; HUMANS; LASER THERAPY; MAGNETIC RESONANCE IMAGING; MALE; PROSTATIC NEOPLASMS; ULTRASONIC THERAPY;

EID: 84888247386     PISSN: 11959479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Noguchi M, Stamey TA, McNeal JE et al. Prognostic factors for multifocal prostate cancer in radical prostatectomy specimens: lack of significance of secondary cancers. J Urol 2003;170(2 Pt 1):459-463.
2. Crouzet S, Rebillard X, Chevallier D et al. Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients. Eur Urol 2010;58(4):559-566.
3. Villers A, McNeal JE, Freiha FS et al. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 1992;70(9):2313-2318.
4. Freiha FS, McNeal JE, Stamey TA. Selection criteria for radical prostatectomy based on morphometric studies in prostate carcinoma. NCI Monogr 1988;(7):107-108.
5. Liu W, Laitinen S, Khan S et al. Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 2009;15(5):559-565.
6. Lian H, Guo H, Gan W et al. Cryosurgery as primary treatment for localized prostate cancer. Int Urol Nephrol 2011;43(4):1089-1094.
7. Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med 2009;361(17):1704-1706.
8. Onik G, Vaughan D, Lotenfoe R et al. The "male lumpectomy": focal therapy for prostate cancer using cryoablation results in 48 patients with at least 2-year follow-up. Urol Oncol 2008;26(5):500-505.
9. Bouza C, López T, Magro A et al. Systematic review and metaanalysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia. BMC Urol 2006;6:14.
10. Onik G, Barzell W. Transperineal 3D mapping biopsy of the prostate: an essential tool in selecting patients for focal prostate cancer therapy. Urol Oncol 2008;26(5):506-510.
11. Colin P, Mordon S, Nevoux P et al. Focal laser ablation of prostate cancer: definition, needs, and future. Adv Urol 2012;2012 :589160.
12. Langer DL, van der Kwast TH, Evans AJ et al. Prostate cancer detection with multi-parametric MRI: logistic regression analysis of quantitative T2, diffusion-weighted imaging, and dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009;30(2):327-334.
13. Rouvière O, Souchon R, Salomir R et al. Transrectal high-intensity focused ultrasound ablation of prostate cancer: effective treatment requiring accurate imaging. Eur J Radiol 2007;63(3):317-327.
14. Weinreb JC, Blume JD, Coakley FV et al. Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology 2009;251(1):122-133.
15. Quint LE, Van EJ, Bland PH et al. Prostate cancer: correlation of MR images with tissue optical density at pathologic examination. Radiology 1991;179(3):837-842.
16. Sommer FG, Nghiem HV, Herfkens R et al. Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil. AJR Am J Roentgenol 1993;161(1):81-86.
17. Aus G. Current status of HIFU and cryotherapy in prostate cancer - a review. Eur Urol 2006;50(5):927-934.
18. Mouraviev V, Polascik TJ. Update on cryotherapy for prostate cancer in 2006. Curr Opin Urol 2006;16(3):152-156.
19. Bahn D, de Castro Abreu AL, Gill IS et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol 2012;62(1):55-63.
20. Algaba F, Montironi R. Impact of prostate cancer multifocality on its biology and treatment. J Endourol 2010;24(5):799-804.
21. Wise AM, Stamey TA, McNeal JE et al. Morphologic and clinical significance of multifocal prostate cancers in radical prostatectomy specimens. Urology 2002;60(2):264-269.
22. Saranathan M, Rettmann DW, Hargreaves BA et al. DIfferential subsampling with cartesian ordering (DISCO): A high spatiotemporal resolution dixon imaging sequence for multiphasic contrast enhanced abdominal imaging. J Magn Reson Imaging 2012;35(6):1484-1492.
23. Gangi A, Tsoumakidou G, Abdelli O et al. Percutaneous MRguided cryoablation of prostate cancer: initial experience. Eur Radiol 2012;22(8):1829-1835.
24. Lecornet E, Ahmed HU, Moore CM et al. Conceptual basis for focal therapy in prostate cancer. J Endourol 2010;24(5):811-818.
25. Lecornet E, Ahmed HU, Moore C et al. Focal therapy for prostate cancer: a potential strategy to address the problem of overtreatment. Arch Esp Urol 2010;63(10):845-852.
26. Jones JS. Focal or subtotal therapy for early stage prostate cancer. Curr Treat Options Oncol 2007;8(3):165-172.
27. Katahira K, Takahara T, Kwee TC et al. Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol 2011;21(1):188-196.
28. Kim CK, Park BK, Kim B. High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR Am J Roentgenol 2010;194(1): W33-W377.
29. Turkbey B, Xu S, Kruecker J, et al. Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI. Cancer Imaging 2011;11:31-36.
30. Fütterer JJ, Barentsz JO. MRI-guided and robotic-assisted prostate biopsy. Curr Opin Urol 2012;22(4):316-319.
31. Turkbey B, Mani H, Shah V et al. Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. J Urol 2011;186(5):1818-1824.
32. Delongchamps NB, Rouanne M, Flam T et al. Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2-weighted, dynamic contrast-enhanced and diffusion-weighted imaging. BJU Int 2011;107(9):1411-1418.
33. Bittencourt LK, Barentsz JO, de Miranda LCD et al. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours. Eur Radiol 2012;22(2):468-475.
34. Nau WH, Diederich CJ, Burdette EC. Evaluation of multielement catheter-cooled interstitial ultrasound applicators for hightemperature thermal therapy. Med Phys 2001;28(7):1525-1534.
35. Diederich CJ, Stafford RJ, Nau WH et al. Transurethral ultrasound applicators with directional heating patterns for prostate thermal therapy: in vivo evaluation using magnetic resonance thermometry. Med Phys 2004;31(2):405-413.
36. Diederich CJ, Nau WH, Stauffer PR. Ultrasound applicators for interstitial thermal coagulation. IEEE Trans. Ultrason. Ferroelectr. Freq Control (USA) 1999;46(5):1218-1228.
37. Ross AB, Diederich CJ, Nau WH et al. Curvilinear transurethral ultrasound applicator for selective prostate thermal therapy. Med Phys 2005;32(6):1555-1565.
38. Ross AB, Diederich CJ, Sommer G et al. Highly directional transurethral ultrasound applicators with rotational control for MRI-guided prostatic thermal therapy. Phys Med Biol 2004;49(2):189-204.
39. Nau WH, Diederich CJ, Ross AB et al. MRI-guided interstitial ultrasound thermal therapy of the prostate: a feasibility study in the canine model. Med Phys 2005;32(3):733-743.
40. Diederich CJ, Nau WH, Burdette EC et al. Combination of transurethral and interstitial ultrasound applicators for hightemperature prostate thermal therapy. Int J Hyperthermia 2000;16(5):385-403.
41. Ross AB, Diederich CJ, Nau WH et al. Highly directional transurethral ultrasound applicators with rotational control for MRI guided prostatic thermal therapy. Phys Med Biol 2004;49(1):189-204.
42. Diederich CJ. Interstitial ultrasound applicators are practical from an engineering perspective for treating large tumours [letter; comment]. Int J Hyperthermia 1996;12(2):305-306.
43. Kinsey AM, Diederich CJ, Tyreus PD et al. Multisectored interstitial ultrasound applicators for dynamic angular control of thermal therapy. Med Phys 2006;33(5):1352-1363.
44. Kinsey AM, Diederich CJ, Rieke V et al. Transurethral ultrasound applicators with dynamic multi-sector control for prostate thermal therapy: in vivo evaluation under MR guidance. Med Phys 2008;35(5):2081-2093.
45. Isebaert S, Van den Bergh L, Haustermans K et al. Multiparametric MRI for prostate cancer localization in correlation to wholemount histopathology. J Magn Reson Imaging 2012:epub ahead of print.
46. Langer DL, van der Kwast TH, Evans AJ et al. Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, K (trans), v (e), and corresponding histologic features. Radiology 2010;255(2):485-494.
47. Kincaide LF, Sanghvi NT, Cummings O et al. Noninvasive ultrasonic subtotal ablation of the prostate in dogs. Am J Vet Res 1996;57(8):1225-1227.
48. Saritas EU, Cunningham CH, Lee JH et al. DWI of the spinal cord with reduced FOV single-shot EPI. Magn Reson Med 2008;60(2):468-473.
49. Gelet A, Chapelon JY, Margonari J et al. Prostatic tissue destruction by high-intensity focused ultrasound: experimentation on canine prostate. J Endourol 1993;7(3):249-253.
50. Bill-Axelson A, Holmberg L, Filén F. Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trial. J Natl Cancer Inst 2008;100(16):1144-1154
51. Chen J, Daniel BL, Diederich CJ et al. Monitoring prostate thermal therapy with diffusion-weighted MRI. Magn Reson Med 2008;59(6):1365-1372.
52. Rieke V, Kinsey AM, Ross AB et al. Referenceless MR thermometry for monitoring thermal ablation in the prostate. IEEE Trans Med Imaging 2007;26(6):813-821.
53. Rieke V, Vigen KK, Sommer G et al. Referenceless PRF shift thermometry. Magn Reson Med 2004;51(6):1223-1231.
54. Pauly KB, Diederich CJ, Rieke V et al. Magnetic resonanceguided high-intensity ultrasound ablation of the prostate. Top Magn Reson Imaging 2006;17(3):195-207.
55. Holbrook A, Santos J, Kaye E. Real-time MR thermometry for monitoring HIFU ablations of the liver. Magn Reson Med 2010;63(2):365-373.
56. Boyes A, Tang K, Yaffe M et al. Prostate tissue analysis immediately following magnetic resonance imaging guided transurethral ultrasound thermal therapy. J Urol 2007;178(3 Pt 1):1080-1085.
57. Wilt TJ, Brawer MK, Jones KM et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012;367(3):203-213.
58. Nau N, Diederich C, Ross A et al. Evaluation of endorectal and urethral cooling devices during MR-guided ultrasound thermal ablation in canine prostate. Conf Proc IEEE Eng Med Biol Soc 2004;4:2492-2495.
59. Burtnyk M, Chopra R, Bronskill M. Simulation study on the heating of the surrounding anatomy during transurethral ultrasound prostate therapy: A 3D theoretical analysis of patient safety. Med Phys 2010;37(6):2862-2875.
60. Lancaster C, Toi A, Trachtenberg J. Interstitial microwave thermoablation for localized prostate cancer. Urology 1999;53(4):828-831.
61. Da Rosa MR, Trachtenberg J, Chopra R et al. Early experience in MRI-guided therapies of prostate cancer: HIFU, laser and photodynamic treatment. Cancer Imaging 2011;11 Spec No A:S3-S8.
62. Siddiqui K, Chopra R, Vedula S et al. MRI-guided transurethral ultrasound therapy of the prostate gland using real-time thermal mapping: initial studies. Urology 2010;76(6):1506-1511.